Infliximab Treatment of Intravenous Immunoglobulin–Resistant Kawasaki Disease
Top Cited Papers
- 31 July 2008
- journal article
- research article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 153 (6) , 833-838.e6
- https://doi.org/10.1016/j.jpeds.2008.06.011
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Induction and Maintenance Infliximab Therapy for the Treatment of Moderate-to-Severe Crohn’s Disease in ChildrenGastroenterology, 2007
- Infliximab for Kawasaki syndromeThe Journal of Pediatrics, 2006
- An Enzyme-Linked Immunosorbent Assay for Therapeutic Drug Monitoring of InfliximabTherapeutic Drug Monitoring, 2006
- Serious liver disease induced by infliximabClinical Rheumatology, 2006
- The effect of TNF? blockade in complicated, refractory Kawasaki diseaseScandinavian Journal of Rheumatology, 2006
- Infliximab treatment for refractory Kawasaki syndromeThe Journal of Pediatrics, 2005
- The relationship of serum infliximab concentrations to clinical improvement in rheumatoid arthritis: Results from ATTRACT, a multicenter, randomized, double‐blind, placebo‐controlled trialArthritis & Rheumatism, 2002
- Construction and initial characterization of a mouse-human chimeric anti-TNF antibodyMolecular Immunology, 1993
- Gamma globulin re-treatment in Kawasaki diseaseThe Journal of Pediatrics, 1993
- Serum levels of tumor necrosis factor, interleukin 2 receptor, and interferon-γ in Kawasaki disease involved coronary-artery lesionsClinical Immunology and Immunopathology, 1990